|
|
|
|
Direct Cost |
Indirect Cost |
|
1F30DK142444-01 |
Metabolic consequences of zonal defects in gluconeogenesis |
UT SOUTHWESTERN MEDICAL CENTER |
NIDDK |
$39,959 |
|
$39,959 |
1F30DK142445-01A1 |
Uncovering the mechanistic drivers of hepatic dysfunction in LIPT1 deficiency |
UT SOUTHWESTERN MEDICAL CENTER |
NIDDK |
$43,127 |
|
$43,127 |
1F31GM154433-01A1 |
Investigating the role of the RNA helicase F57B9.3 in translational regulation under conditions of lipid depletion |
UT SOUTHWESTERN MEDICAL CENTER |
NIGMS |
$40,127 |
|
$40,127 |
1K02NS140483-01 |
Role of HP1β-mediated heterochromatin organization in neurodevelopmental disorders: CBX1-related syndrome as a model |
UT SOUTHWESTERN MEDICAL CENTER |
NINDS |
$245,000 |
$19,600 |
$264,600 |
1K08DK138291-01A1 |
Elucidating the Role of NAD+ and PARylation in Nephron Endowment |
UT SOUTHWESTERN MEDICAL CENTER |
NIDDK |
$156,376 |
$12,510 |
$168,886 |
1K23DK141959-01 |
Survivorship Trajectories After Liver Transplantation: Identifying At‐Risk Survivors Needing Intervention |
UT SOUTHWESTERN MEDICAL CENTER |
NIDDK |
$169,368 |
$13,321 |
$182,689 |
1K99CA283246-01A1 |
Data-driven mechanistic models of morphology-controlled Ras oncogenic signaling |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$129,719 |
$10,378 |
$140,097 |
1R01AI187273-01 |
Androgens modulate Staphylococcus aureus signaling and pathogenesis |
UT SOUTHWESTERN MEDICAL CENTER |
NIAID |
$471,269 |
$172,345 |
$643,614 |
1R01AI190103-01 |
Machine learning for identifying antigen-antibody interactions from massive sequencing data |
UT SOUTHWESTERN MEDICAL CENTER |
NIAID |
$535,362 |
$131,651 |
$667,013 |
1R01AR083904-01A1 |
Metabolic regulation of osteoclast differentiation and bone resorption |
UT SOUTHWESTERN MEDICAL CENTER |
NIAMS |
$358,721 |
$229,581 |
$588,302 |
1R01AR084498-01A1 |
ABC Hydrogel for the treatment of osteonecrosis |
UT SOUTHWESTERN MEDICAL CENTER |
NIAMS |
$248,812 |
$64,059 |
$312,871 |
1R01AR085116-01 |
Molecular Mechanisms of Myoblast Fusion |
UT SOUTHWESTERN MEDICAL CENTER |
NIAMS |
$274,136 |
$165,655 |
$439,791 |
1R01CA286912-01A1 |
Acquired Cross-Resistance through MYC Amplification in Small Cell Lung Cancer |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$395,118 |
$247,311 |
$642,429 |
1R01CA288743-01A1 |
Small Compound Inhibitors Targeting HPV Genome Replication |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$435,734 |
$224,471 |
$660,205 |
1R01CA289251-01A1 |
Decoding the metabolic routes of purine nucleotides in cancer - Resubmission - 1 |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$331,999 |
$212,479 |
$544,478 |
1R01CA289260-01A1 |
Metabolic mechanisms of glioma progression |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$495,764 |
$186,832 |
$682,596 |
1R01CA289534-01A1 |
Mechanisms and Models of Testis Specific Serine Kinase 6: A Novel Therapeutic Target in Colorectal Cancer |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$299,894 |
$191,932 |
$491,826 |
1R01CA294133-01A1 |
Genome-wide CRISPR screening identifies critical regulators controlling ccRCC lung metastasis |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$318,036 |
$203,543 |
$521,579 |
1R01CA295762-01 |
Overcoming mechanisms of PTPN1 driving therapy- and castration- resistant prostate cancer with novel theranostics |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$288,084 |
$184,374 |
$472,458 |
1R01CA295997-01 |
Mechanisms and Consequences of PAX2 Inactivation in the Initiation of Endometrial Carcinogenesis |
UT SOUTHWESTERN MEDICAL CENTER |
NCI |
$336,570 |
$215,405 |
$551,975 |